Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 18Prostatic Neoplasms, Castration-Resistant 3Neoplasm Metastasis 3Non-metastatic Castration-resistant Prostate Cancer 2Metastatic Castration Resistant Prostate Cancer 2Sleep Initiation and Maintenance Disorders 1Non-metastatic Prostate Cancer 1Metastatic Hormone-sensitive Prostate Cancer 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Fatigue 1Epilepsy 1Depression 1Castration-resistant Prostate Cancer 1Brain Diseases 1Advanced Prostate Carcinoma 1

Interventions

enzalutamide 1darolutamide 1apalutamide 1abiraterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Advanced Prostate Carcinoma × enzalutamide × Clear all
NCT05612880 2025-01-09

Physical Function During ARSI Treatment

UNC Lineberger Comprehensive Cancer Center

Completed
24 enrolled
Genitourinary

Advanced Prostate Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡